Skip to main content

Transthoracic echocardiography of hypertrophic cardiomyopathy in adults: a practical guideline from the British Society of Echocardiography

Abstract

Hypertrophic cardiomyopathy (HCM) is common, inherited and characterised by unexplained thickening of the myocardium. The British Society of Echocardiography (BSE) has recently published a minimum dataset for transthoracic echocardiography detailing the core views needed for a standard echocardiogram. For patients with confirmed or suspected HCM, additional views and measurements are necessary. This guideline, therefore, supplements the minimum dataset and describes a tailored, stepwise approach to the echocardiographic examination, and echocardiography’s position in the diagnostic pathway, before advising on the imaging of disease complications and invasive treatments.

References

  1. Smith N, Steeds R, Masani N, Sandoval J, Wharton G, Allen J, Chambers J, Jones R, Lloyd G, Rana B, et al. A systematic approach to echocardiography in hypertrophic cardiomyopathy: a guideline protocol from the British Society of Echocardiography. Echo Research and Practice 20152 G1–G7. (https://doi.org/10.1530/ERP-14-0115)

    Article  PubMed  PubMed Central  Google Scholar 

  2. Authors/Task Force members, Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, Hagege AA, Lafont A, Limongelli G, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). European Heart Journal 201435 2733–2779. (https://doi.org/10.1093/eurheartj/ehu284)

    Article  PubMed  Google Scholar 

  3. Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE, Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA study. Circulation 199592 785–789. (https://doi.org/10.1161/01.cir.92.4.785)

    Article  CAS  PubMed  Google Scholar 

  4. Massera D, McClelland RL, Ambale‐Venkatesh B, Gomes AS, Hundley WG, Kawel‐Boehm N, Yoneyama K, Owens DS, Garcia MJ, Sherrid MV, et al. Prevalence of unexplained left ventricular hypertrophy by cardiac magnetic resonance imaging in MESA. Journal of the American Heart Association 20198 e012250. (https://doi.org/10.1161/JAHA.119.012250)

    Article  PubMed  PubMed Central  Google Scholar 

  5. Ho CY, Day SM, Ashley EA, Michels M, Pereira AC, Jacoby D, Cirino AL, Fox JC, Lakdawala NK, Ware JS, et al. Genotype and lifetime burden of disease in hypertrophic cardiomyopathy: insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe). Circulation 2018138 1387–1398. (https://doi.org/10.1161/CIRCULATIONAHA.117.033200)

    Article  PubMed  PubMed Central  Google Scholar 

  6. Marstrand P, Han L, Day SM, Olivotto I, Ashley EA, Michels M, Pereira AC, Wittekind SG, Helms A, Saberi S, et al. Hypertrophic cardiomyopathy with left ventricular systolic dysfunction: insights from the SHaRe Registry. Circulation 2020141 1371–1383. (https://doi.org/10.1161/CIRCULATIONAHA.119.044366)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Alfares AA, Kelly MA, McDermott G, Funke BH, Lebo MS, Baxter SB, Shen J, McLaughlin HM, Clark EH, Babb LJ, et al. Results of clinical genetic testing of 2912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity. Genetics in Medicine 201517 880–888. (https://doi.org/10.1038/gim.2014.205)

    Article  PubMed  Google Scholar 

  8. Flett AS, Maestrini V, Milliken D, Fontana M, Treibel TA, Harb R, Sado DM, Quarta G, Herrey A, Sneddon J, et al. Diagnosis of apical hypertrophic cardiomyopathy: T-wave inversion and relative but not absolute apical left ventricular hypertrophy. International Journal of Cardiology 2015183 143–148. (https://doi.org/10.1016/j.ijcard.2015.01.054)

    Article  PubMed  Google Scholar 

  9. Suzuki J, Shimamoto R, Nishikawa J, Yamazaki T, Tsuji T, Nakamura F, Shin WS, Nakajima T, Toyo-Oka T, Ohotomo K, Morphological onset and early diagnosis in apical hypertrophic cardiomyopathy: a long term analysis with nuclear magnetic resonance imaging. Journal of the American College of Cardiology 199933 146–151. (https://doi.org/10.1016/s0735-1097(9800527-0)

    Article  CAS  PubMed  Google Scholar 

  10. Norrish G, Jager J, Field E, Quinn E, Fell H, Lord E, Cicerchia MN, Ochoa JP, Cervi E, Elliott PM, et al. Yield of clinical screening for hypertrophic cardiomyopathy in child first-degree relatives. Circulation 2019140 184–192. (https://doi.org/10.1161/CIRCULATIONAHA.118.038846)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. van Velzen HG, Schinkel AFL, Baart SJ, Oldenburg RA, Frohn-Mulder IME, van Slegtenhorst MA, Michels M, Outcomes of contemporary family screening in hypertrophic cardiomyopathy. Circulation: Genomic and Precision Medicine 201811 e001896. (https://doi.org/10.1161/CIRCGEN.117.001896)

  12. Coppini R, Ho CY, Ashley E, Day S, Ferrantini C, Girolami F, Tomberli B, Bardi S, Torricelli F, Cecchi F, et al. Clinical phenotype and outcome of hypertrophic cardiomyopathy associated With thin-filament gene mutations. Journal of the American College of Cardiology 201464 2589–2600. (https://doi.org/10.1016/j.jacc.2014.09.059)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. van Velzen HG, Schinkel AFL, Oldenburg RA, van Slegtenhorst MA, Frohn-Mulder IME, van der Velden J, Michels M, Clinical characteristics and long-term outcome of hypertrophic cardiomyopathy in individuals with a MYBPC3 (myosin-binding protein C) founder mutation. Circulation: Cardiovascular Genetics 201710 [epub]. (https://doi.org/10.1161/CIRCGENETICS.116.001660)

  14. Page SP, Kounas S, Syrris P, Christiansen M, Frank-Hansen R, Andersen PS, Elliott PM, McKenna WJ, Cardiac myosin binding protein-C mutations in families with hypertrophic cardiomyopathy: disease expression in relation to age, gender, and long term outcome. Circulation: Cardiovascular Genetics 20125 156–166. (https://doi.org/10.1161/CIRCGENETICS.111.960831)

    CAS  Google Scholar 

  15. Sheikh N, Papadakis M, Carre F, Kervio G, Panoulas VF, Ghani S, Zaidi A, Gati S, Rawlins J, Wilson MG, et al. Cardiac adaptation to exercise in adolescent athletes of African ethnicity: an emergent elite athletic population. British Journal of Sports Medicine 201347 585–592. (https://doi.org/10.1136/bjsports-2012-091874)

    Article  PubMed  Google Scholar 

  16. Sheikh N, Papadakis M, Schnell F, Panoulas V, Malhotra A, Wilson M, Carré F, Sharma S, Clinical profile of athletes with hypertrophic cardiomyopathy. Circulation: Cardiovascular Imaging 20158 e003454. (https://doi.org/10.1161/CIRCIMAGING.114.003454)

  17. Harkness A, Ring L, Augustine DX, Oxborough D, Robinson S, Sharma V, Education Committee of the British Society of Echocardiography. Normal reference intervals for cardiac dimensions and function for use in echocardiographic practice: a guideline from the British Society of Echocardiography. Echo Research and Practice 20207 G1–G18.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Caselli S, Maron MS, Urbano-Moral JA, Pandian NG, Maron BJ, Pelliccia A, Differentiating left ventricular hypertrophy in athletes from that in patients with hypertrophic cardiomyopathy. American Journal of Cardiology 2014114 1383–1389. (https://doi.org/10.1016/j.amjcard.2014.07.070)

    Article  PubMed  Google Scholar 

  19. Pelliccia A, Maron BJ, De Luca R, Di Paolo FM, Spataro A, Culasso F, Remodeling of left ventricular hypertrophy in elite athletes after long-term deconditioning. Circulation 2002105 944–949. (https://doi.org/10.1161/hc0802.104534)

    Article  PubMed  Google Scholar 

  20. Rapezzi C, Arbustini E, Caforio ALP, Charron P, Gimeno-Blanes J, Heliö T, Linhart A, Mogensen J, Pinto Y, Ristic A, et al. Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases. European Heart Journal 201334 1448–1458. (https://doi.org/10.1093/eurheartj/ehs397)

    Article  PubMed  Google Scholar 

  21. Binder J, Ommen SR, Gersh BJ, Van Driest SL, Tajik AJ, Nishimura RA, Ackerman MJ, Echocardiography-guided genetic testing in hypertrophic cardiomyopathy: septal morphological features predict the presence of myofilament mutations. Mayo Clinic Proceedings 200681 459–467. (https://doi.org/10.4065/81.4.459)

    Article  PubMed  Google Scholar 

  22. Kwon DH, Setser RM, Thamilarasan M, Popovic ZV, Smedira NG, Schoenhagen P, Garcia MJ, Lever HM, Desai MY, Abnormal papillary muscle morphology is independently associated with increased left ventricular outflow tract obstruction in hypertrophic cardiomyopathy. Heart 200894 1295–1301. (https://doi.org/10.1136/hrt.2007.118018)

    Article  CAS  PubMed  Google Scholar 

  23. Klues HG, Roberts WC, Maron BJ, Anomalous insertion of papillary muscle directly into anterior mitral leaflet in hypertrophic cardiomyopathy. Significance in producing left ventricular outflow obstruction. Circulation 199184 1188–1197. (https://doi.org/10.1161/01.cir.84.3.1188)

    Article  CAS  PubMed  Google Scholar 

  24. Lentz Carvalho J, Schaff HV, Morris CS, Nishimura RA, Ommen SR, Maleszewski JJ, Dearani JA, Anomalous papillary muscles-Implications in the surgical treatment of hypertrophic obstructive cardiomyopathy. Journal of Thoracic and Cardiovascular Surgery 2020 [epub]. (https://doi.org/10.1016/j.jtcvs.2020.04.007)

    Google Scholar 

  25. Gruner C, Chan RH, Crean A, Rakowski H, Rowin EJ, Care M, Deva D, Williams L, Appelbaum E, Gibson CM, et al. Significance of left ventricular apical–basal muscle bundle identified by cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy. European Heart Journal 201435 2706–2713. (https://doi.org/10.1093/eurheartj/ehu154)

    Article  PubMed  Google Scholar 

  26. Rowin EJ, Maron BJ, Haas TS, Garberich RF, Wang W, Link MS, Maron MS, Hypertrophic cardiomyopathy with left ventricular apical aneurysm: implications for risk stratification and management. Journal of the American College of Cardiology 201769 761–773. (https://doi.org/10.1016/j.jacc.2016.11.063)

    Article  PubMed  Google Scholar 

  27. Hiemstra YL, Debonnaire P, Bootsma M, van Zwet EW, Delgado V, Schalij MJ, Atsma DE, Bax JJ, Marsan NA, Global longitudinal strain and left atrial volume index provide incremental prognostic value in patients with hypertrophic cardiomyopathy. Circulation: Cardiovascular Imaging 201710 e005706. (https://doi.org/10.1161/CIRCIMAGING.116.005706)

  28. Maron MS, Rowin EJ, Wessler BS, Mooney PJ, Fatima A, Patel P, Koethe BC, Romashko M, Link MS, Maron BJ, Enhanced American College of Cardiology/American Heart Association strategy for prevention of sudden cardiac death in high-risk patients with hypertrophic cardiomyopathy. JAMA Cardiology 20194 644–657. (https://doi.org/10.1001/jamacardio.2019.1391)

    Article  PubMed  PubMed Central  Google Scholar 

  29. O’Mahony C, Jichi F, Pavlou M, Monserrat L, Anastasakis A, Rapezzi C, Biagini E, Gimeno JR, Limongelli G, McKenna WJ, et al. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD). European Heart Journal 201435 2010–2020. (https://doi.org/10.1093/eurheartj/eht439)

    Article  PubMed  Google Scholar 

  30. Guttmann OP, Pavlou M, O’Mahony C, Monserrat L, Anastasakis A, Rapezzi C, Biagini E, Gimeno JR, Limongelli G, Garcia-Pavia P, et al. Prediction of thrombo‐embolic risk in patients with hypertrophic cardiomyopathy (HCM Risk‐CVA). European Journal of Heart Failure 201517 837–845. (https://doi.org/10.1002/ejhf.316)

    Article  PubMed  Google Scholar 

  31. Rowin EJ, Maron BJ, Kiernan MS, Casey SA, Feldman DS, Hryniewicz KM, Chan RH, Harris KM, Udelson JE, DeNofrio D, et al. Advanced heart failure with preserved systolic function in nonobstructive hypertrophic cardiomyopathy: under-recognized subset of candidates for heart transplant. Circulation: Heart Failure 20147 967–975. (https://doi.org/10.1161/CIRCHEARTFAILURE.114.001435)

    Google Scholar 

  32. Biagini E, Spirito P, Rocchi G, Ferlito M, Rosmini S, Lai F, Lorenzini M, Terzi F, Bacchi-Reggiani L, Boriani G, et al. Prognostic implications of the Doppler restrictive filling pattern in hypertrophic cardiomyopathy. American Journal of Cardiology 2009104 1727–1731. (https://doi.org/10.1016/j.amjcard.2009.07.057)

    Article  PubMed  Google Scholar 

  33. Hang D, Schaff HV, Nishimura RA, Lahr BD, Abel MD, Dearani JA, Ommen SR, Accuracy of jet direction on Doppler echocardiography in identifying the etiology of mitral regurgitation in obstructive hypertrophic cardiomyopathy. Journal of the American Society of Echocardiography 201932 333–340. (https://doi.org/10.1016/j.echo.2018.10.011)

    Article  PubMed  Google Scholar 

  34. Reant P, Dufour M, Peyrou J, Reynaud A, Rooryck C, Dijos M, Vincent C, Cornolle C, Roudaut R, Lafitte S, Upright treadmill vs. semi-supine bicycle exercise echocardiography to provoke obstruction in symptomatic hypertrophic cardiomyopathy: a pilot study. European Heart Journal Cardiovascular Imaging 201819 31–38. (https://doi.org/10.1093/ehjci/jew313)

    Article  PubMed  Google Scholar 

  35. Feiner E, Arabadjian M, Winson G, Kim B, Chaudhry F, Sherrid MV, Post-prandial upright exercise echocardiography in hypertrophic cardiomyopathy. Journal of the American College of Cardiology 201361 2487–2488. (https://doi.org/10.1016/j.jacc.2013.02.079)

    Article  PubMed  Google Scholar 

  36. Zemánek D, Tomašov P, Homolová S, Linhartová K, Veselka J, Sublingual isosorbide dinitrate for the detection of obstruction in hypertrophic cardiomyopathy. European Journal of Echocardiography 201112 684–687. (https://doi.org/10.1093/ejechocard/jer115)

    Article  PubMed  Google Scholar 

  37. Hoit BD, Strain and strain rate echocardiography and coronary artery disease. Circulation: Cardiovascular Imaging 20114 179–190. (https://doi.org/10.1161/CIRCIMAGING.110.959817)

    Google Scholar 

  38. Haland TF, Almaas VM, Hasselberg NE, Saberniak J, Leren IS, Hopp E, Edvardsen T, Haugaa KH, Strain echocardiography is related to fibrosis and ventricular arrhythmias in hypertrophic cardiomyopathy. European Heart Journal Cardiovascular Imaging 201617 613–621. (https://doi.org/10.1093/ehjci/jew005)

    Article  PubMed  PubMed Central  Google Scholar 

  39. Tower-Rader A, Mohananey D, To A, Lever HM, Popovic ZB, Desai MY, Prognostic value of global longitudinal strain in hypertrophic cardiomyopathy: a systematic review of existing literature. JACC: Cardiovascular Imaging 201912 1930–1942. (https://doi.org/10.1016/j.jcmg.2018.07.016)

    PubMed  Google Scholar 

  40. Nampiaparampil RG, Swistel DG, Schlame M, Saric M, Sherrid MV, Intraoperative two- and three-dimensional transesophageal echocardiography in combined myectomy-mitral operations for hypertrophic cardiomyopathy. Journal of the American Society of Echocardiography 201831 275–288. (https://doi.org/10.1016/j.echo.2017.11.016)

    Article  PubMed  Google Scholar 

  41. Vainrib A, Massera D, Sherrid MV, Swistel DG, Bamira D, Ibrahim H, Staniloae C, Williams MR, Saric M, Three-dimensional imaging and dynamic modeling of systolic anterior motion of the mitral valve. Journal of the American Society of Echocardiography 202134 89–96. (https://doi.org/10.1016/j.echo.2020.08.019)

    Article  PubMed  Google Scholar 

  42. Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, Naidu SS, Nishimura RA, Ommen SR, Rakowski H, et al. ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy. Circulation 2011124 e783–e831. (https://doi.org/10.1161/CIR.0b013e318223e2bd)

    PubMed  Google Scholar 

  43. Nistri S, Olivotto I, Betocchi S, Losi MA, Valsecchi G, Pinamonti B, Conte MR, Casazza F, Galderisi M, Maron BJ, et al. Prognostic significance of left atrial size in patients with hypertrophic cardiomyopathy (from the Italian Registry for Hypertrophic Cardiomyopathy). American Journal of Cardiology 200698 960–965. (https://doi.org/10.1016/j.amjcard.2006.05.013)

    Article  PubMed  Google Scholar 

  44. Maron MS, Olivotto I, Betocchi S, Casey SA, Lesser JR, Losi MA, Cecchi F, Maron BJ, Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. New England Journal of Medicine 2003348 295–303. (https://doi.org/10.1056/NEJMoa021332)

    Article  PubMed  Google Scholar 

  45. Harris KM, Spirito P, Maron MS, Zenovich AG, Formisano F, Lesser JR, Mackey-Bojack S, Manning WJ, Udelson JE, Maron BJ, Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy. Circulation 2006114 216–225. (https://doi.org/10.1161/CIRCULATIONAHA.105.583500)

    Article  PubMed  Google Scholar 

  46. Augustine DX, Coates-Bradshaw LD, Willis J, Harkness A, Ring L, Grapsa J, Coghlan G, Kaye N, Oxborough D, Robinson S, et al. Echocardiographic assessment of pulmonary hypertension: a guideline protocol from the British Society of Echocardiography. Echo Research and Practice 20185 G11–G24. (https://doi.org/10.1530/ERP-17-0071)

    Article  PubMed  PubMed Central  Google Scholar 

  47. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS, et al. American Heart Association Writing Group on myocardial segmentation and registration for cardiac imaging. Circulation 2002105 539–542. (https://doi.org/10.1161/hc0402.102975)

    Article  PubMed  Google Scholar 

  48. Ho CY, Sweitzer NK, McDonough B, Maron BJ, Casey SA, Seidman JG, Seidman CE, Solomon SD, Assessment of diastolic function with Doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy. Circulation 2002105 2992–2997. (https://doi.org/10.1161/01.cir.0000019070.70491.6d)

    Article  PubMed  Google Scholar 

  49. Patel P, Dhillon A, Popovic ZB, Smedira NG, Rizzo J, Thamilarasan M, Agler D, Lytle BW, Lever HM, Desai MY, Left ventricular outflow tract obstruction in hypertrophic cardiomyopathy patients Without severe septal hypertrophy: implications of mitral valve and papillary muscle abnormalities assessed using cardiac magnetic resonance and echocardiography. Circulation: Cardiovascular Imaging 20158 e003132. (https://doi.org/10.1161/CIRCIMAGING.115.003132)

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to William Bradlow.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the articles Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the articles Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Turvey, L., Augustine, D.X., Robinson, S. et al. Transthoracic echocardiography of hypertrophic cardiomyopathy in adults: a practical guideline from the British Society of Echocardiography. Echo Res Pract 8, G61–G86 (2021). https://doi.org/10.1530/ERP-20-0042

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1530/ERP-20-0042

Keywords

  • hypertrophic cardiomyopathy
  • hypertrophic obstructive cardiomyopathy
  • guidelines
  • echocardiography